BACKGROUND AND OBJECTIVES: Persistent idiopathic facial pain is a chronic disease with neuropathic origin, whose etiology is usually unknown; it is a medical condition that does not respond satisfactorily to drug therapy. It is also a disease with a major impact on patient quality of life and difficult to diagnose. This study aimed to report the diagnosis of a complex, persistent idiopathic facial pain, the pharmacological intervention taken and the adoption of integrative and complementary practices for the management of persistent idiopathic facial, as well as the clinical course and the impact of these actions on the patient's quality of life. CASE REPORT: A female patient, 52, diagnosed 06 years ago as a carrier of persistente idiopathic facial pain associated with bruxism and temporomandibular disorders. The patient presented with a complaint of orofacial pain which did not meet the diagnostic criteria for temporomandibular disorders. The patient also presented myofascial and trigeminal neuralgia pain in the left buccal region which emerged after performing a root canal procedure. The therapeutic plan adopted was based on pharmacological therapy with pregabalin (450mg) in combination with venlafaxine hydrochloride (150mg), continuously. As additional measures, weekly acupuncture sessions, therapy sessions with psychologists, including hypnosis and meditation, as well as peripheral nerve and a venous block during crises and botulinum toxin application were applied. CONCLUSION: The therapeutic plan adopted led to a considerable improvement in the patient's quality of life, evidenced by the reduction in pain intensity and a decrease in the frequency of painful crises. The need for interdisciplinary monitoring, as it is a multifactorial disease, as well as for the ongoing training of various categories of health professionals involved in the treatment of persistent idiopathic facial, given that it is a complication which is rare and difficult to diagnose, is observed.
ackground Chronic pain leads to functional and social disability, emotionally impacting individuals. Objective: To describe the main impairments of activities of daily living, anxious and depressive symptoms and quality of life in patients with chronic pain. Methods: Cross-sectional study with patients at the Chronic Pain Clinic attended between June / 2016 and March / 2019. Clinical and socio-demographic variables were collected, using the Hospital scale for Anxiety and Depression, Visual Numerical Scale for Pain, SF-36 scale for Quality of Life, and data analysis using the SPSS statistical program. Results: The mean age was 50.0±10 years, being (89.6%) female. There was a predominance of people with a partner, with religion, complete high school education and unemployed. Degenerative disease was the most frequent diagnosis (68.9%); pain intensity ranged from moderate to severe, score 6-8 (7). Most used drugs were analgesics (93.3%) followed by antidepressants (70.7%). Physical activity as an adjuvant treatment (41.5%), and anesthetic blocks (39.6%). When investigating daily activities, the work showed total limitation followed by movement; and, partially, leisure and home activity. The quality of life was well below the median, with the physical and emotional aspects being worse. Related to the subjects' activities, sleep is the most compromised; followed by partial difficulties with appetite and sexual activity. Most show self-esteem moderately satisfied with the treatment, even with anxious and depressive symptoms. Conclusion: Pain has a very significant impact on quality of life; compromises and limits daily activities and reveals more presence of anxious and depressive symptoms in people suffering from chronic pain.
BACKGROUND AND OBJECTIVES: Chronic pain causes functional and social disability, resulting in emotional impact. This study's objective was to describe the main impairments of activities of daily living, anxious and depressive symptoms, and quality of life in patients with chronic pain. METHODS: Cross-sectional study with chronic pain outpatients. Analysis of clinical and sociodemographic variables, as well as activities of daily living. Assessment of pain, anxious and depressive symptoms by the Hospital Anxiety and Depression Scale, quality of life by the Medical Outcomes Study 36 -Item Short Form Health Survey questionnaire and data analysis by the SPSS statistical software. RESULTS:The study observed limitations in work, movement, leisure and home activities, quality of life below the median and worse for the physical and emotional domains. Sleep was very impaired, followed by partial difficulty with appetite and sexual activity. Although they had anxious and depressive symptoms, most participants were moderately satisfied with their treatment. CONCLUSION: Chronic pain has a very significant impact on quality of life, impairing and limiting daily activities more intensely in individuals with anxious and depressive symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.